<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33879715</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>16</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Sporadic amyotrophic lateral sclerosis with seropositive neuromyelitis optica spectrum disorder: A case report.</ArticleTitle><Pagination><StartPage>e25580</StartPage><MedlinePgn>e25580</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e25580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000025580</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Neuromyelitis optica spectrum disorder (NMOSD) is a severe inflammatory disorder of the central nervous system with an autoantibody against aquaporin-4 protein (AQP4), and amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. We report a female patient with ALS who had asymptomatic AQP4 antibody at the diagnosis of ALS, and NMOSD occurred 4&#x200a;years later after the diagnosis of ALS.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">She was already bedridden and had tracheostomy because of ALS which was diagnosed at her age of 55. At the time of her ALS diagnosis, she had no brain or spinal cord lesions, but was seropositive for AQP4 antibody. At her age of 59, new-onset complete paralysis of all extremities and severe pain on the posterior neck and both shoulders occurred and visited the hospital.</AbstractText><AbstractText Label="DIAGNOSIS" NlmCategory="METHODS">Longitudinally extensive transverse myelitis was diagnosed, which was the onset attack of seropositive NMOSD. The diagnosis was confirmed based on the international consensus diagnostic criteria for NMOSD with MR imaging, cerebrospinal fluid exam and laboratory work-ups with AQP4 antibody test.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">High dose methylprednisolone was administered for 5&#x200a;days. Plasma exchange as a further treatment was recommended, but she and her family refused.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">Her pain was relieved after steroid treatment, but there was no improvement of her leg weakness.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">This case is a rare combination of neuroinflammatory and neurodegenerative diseases. Considering the alterations of blood-brain barrier along with the progression of ALS, it highlights that the consequence of ALS pathogenesis might affect the development of NMOSD. And the careful follow-up is recommended even in patients with profound weakness, especially if those who were at risk of developing certain neurological disorders.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Hye Jeong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yuntae</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seok</LastName><ForeName>Jin Myoung</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>no</GrantID><Agency>Soonchunhyang University Research Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496030">AQP4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051401">Aquaporin 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051401" MajorTopicYN="N">Aquaporin 4</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009471" MajorTopicYN="N">Neuromyelitis Optica</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33879715</ArticleId><ArticleId IdType="pmc">PMC8078316</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000025580</ArticleId><ArticleId IdType="pii">00005792-202104230-00062</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bradl M, Reindl M, Lassmann H. Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Curr Opin Neurol 2018;31:325&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959204</ArticleId><ArticleId IdType="pubmed">29465432</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama S, Ito T, Misu T, et al. . A case of NMO seropositive for aquaporin-4 antibody more than 10&#x200a;years before onset. Neurology 2009;72:1960&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">19487655</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite MI, Coutinho E, Lana-Peixoto M, et al. . Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012;78:1601&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348852</ArticleId><ArticleId IdType="pubmed">22551731</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, et al. . Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res 2012;1469:114&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingerchuk DM, Banwell B, Bennett JL, et al. . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4515040</ArticleId><ArticleId IdType="pubmed">26092914</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun KY, Park J, Oh KW, et al. . Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 2019;90:395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581156</ArticleId><ArticleId IdType="pubmed">30409890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Park SH, Han K, et al. . Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea. Mult Scler 2019;26:1837&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">31749401</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone YM, Radaelli M, Agosta F, et al. . Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:449&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">31007077</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, McGranahan T, Su E, et al. . Coexistence of neuromyelitis optica and amyotrophic lateral sclerosis: a case report. Neurohospitalist 2019;9:37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327238</ArticleId><ArticleId IdType="pubmed">30671163</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010;6:383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">20639914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritzenthaler T, Dailler F, Vukusic S, et al. . First attack of Devic's neuromyelitis optica following endovascular treatment and rupture of brain arteriovenous malformation. Mult Scler 2011;17:895&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21467187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, et al. . Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:616&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler EA, Sengillo JD, Sullivan JS, et al. . Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 2013;125:111&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, et al. . Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 2013;81:1222&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, Decman V, White D, et al. . C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep 2016;6:23204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JH, Kwon MJ, Choi WJ, et al. . Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2013;34:1311.e7&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23088937</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>